XML 41 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Tables)
9 Months Ended
Oct. 28, 2017
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at October 28, 2017, October 29, 2016 and January 28, 2017. The Company did not have any transfers between Level 1, Level 2 or Level 3 during the thirty-nine weeks ended October 28, 2017 or October 29, 2016.   
 
 

 
Fair Value Measurements
($ thousands)
Total

 
Level 1

Level 2

Level 3

Asset (Liability)
 

 
 

 

 

October 28, 2017:
 
 
 
 
 
Cash equivalents – money market funds
$
14,967

 
$
14,967

$

$

Non-qualified deferred compensation plan assets
6,000

 
6,000



Non-qualified deferred compensation plan liabilities
(6,000
)
 
(6,000
)


Deferred compensation plan liabilities for non-employee directors
(2,350
)
 
(2,350
)


Restricted stock units for non-employee directors
(10,118
)
 
(10,118
)


Derivative financial instruments, net
196

 

196


October 29, 2016:
 
 
 
 
 
Cash equivalents – money market funds
$
152,700

 
$
152,700

$

$

Non-qualified deferred compensation plan assets
4,747

 
4,747



Non-qualified deferred compensation plan liabilities
(4,747
)
 
(4,747
)


Deferred compensation plan liabilities for non-employee directors
(1,596
)
 
(1,596
)


Restricted stock units for non-employee directors
(8,726
)
 
(8,726
)


Performance share units
(2,446
)
 
(2,446
)


Derivative financial instruments, net
(208
)
 

(208
)

Secured convertible note
7,227

 


7,227

January 28, 2017:
 
 
 
 
 
Cash equivalents – money market funds
$
27,530

 
$
27,530

$

$

Non-qualified deferred compensation plan assets
5,051

 
5,051



Non-qualified deferred compensation plan liabilities
(5,051
)
 
(5,051
)


Deferred compensation plan liabilities for non-employee directors
(1,909
)
 
(1,909
)


Restricted stock units for non-employee directors
(9,390
)
 
(9,390
)


Performance share units
(3,352
)
 
(3,352
)


Derivative financial instruments, net
(640
)
 

(640
)

Schedule of Impairment Charges by Segment
This assessment resulted in the following impairment charges, primarily for leasehold improvements and furniture and fixtures in the Company's retail stores, which were included in selling and administrative expenses for the respective periods.

 
Thirteen Weeks Ended
Thirty-Nine Weeks Ended
($ thousands)
October 28, 2017

October 29, 2016

October 28, 2017

October 29, 2016

Impairment Charges
 
 
 
 
Famous Footwear
$
150

$
128

$
450

$
262

Brand Portfolio
726

248

2,545

651

Total impairment charges
$
876

$
376

$
2,995

$
913

Schedule of Fair Value of Financial Instruments
The fair values of cash and cash equivalents (excluding money market funds discussed above), receivables and trade accounts payable approximate their carrying values due to the short-term nature of these instruments.

The carrying amounts and fair values of the Company's other financial instruments subject to fair value disclosures are as follows:
 
October 28, 2017
 
October 29, 2016
 
January 28, 2017
 
Carrying

 
Fair

 
Carrying

 
Fair

 
Carrying

 
Fair

($ thousands)
Value

 
Value

 
Value

 
Value

 
Value

 
Value

Borrowings under revolving credit agreement
$
20,000

 
$
20,000

 
$

 
$

 
$
110,000

 
$
110,000

Long-term debt
197,348

 
209,000

 
196,888

 
209,000

 
197,003

 
209,000

Total debt
$
217,348


$
229,000


$
196,888


$
209,000


$
307,003


$
319,000